Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series
===========================================================================================================================================================================================================

* Abdul Rafeh Naqash
* Danielle M. File
* Carolyn M. Ziemer
* Young E. Whang
* Paula Landman
* Paul B. Googe
* Frances A. Collichio